About 200 reports

Major players in the diuretic market are Merck & Co., Meda Manufacturing GmbH, Pfizer Inc., Glaxosmithkline, Roche, Aton Pharma Inc., Boehringer Ingelheim GmbH, Novartis AG and Teva Pharmaceuticals Industries Ltd. The global diuretics market is expected to grow from $0.60 billion in 2021 to $0.64 billion in 2022 at a compound annual...

  • Pharmaceutical
  • Drug Delivery
  • World
  • United States
  • United Kingdom
  • Japan
  • Middle East
  • APAC

Major players in the diuretic drugs market are Merck & Co., Meda Manufacturing GmbH, Pfizer Inc., Glaxosmithkline and Roche. The global diuretics market is expected to grow from $0.82 billion in 2020 to $0.91 billion in 2021 at a compound annual growth rate (CAGR) of 11%. The growth is mainly due to the companies rearranging their operations...

  • Drug Delivery
  • World
  • Japan
  • United States
  • United Kingdom

Abstract: - Global Anti-Hypertensive Drugs Market to Reach $33.2 Billion by 2027 - Amid the COVID-19 crisis, the global market for Anti-Hypertensive Drugs estimated at US$32.7 Billion in the year 2020, is projected to reach a revised size of US$33.2 Billion by 2027, growing at a CAGR of 0.2% over the analysis period...

  • Antihypertensive
  • World
  • China
  • United States

Diuretics Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery provides strategists, marketers and senior management with the critical information they need to assess the global diuretics drugs market as it emerges from the Covid 19 shut down. Description: Where is the largest and fastest growing market...

  • Pharmacy
  • Marketing Research
  • Heart Failure
  • World

Abstract: - Global Acute Heart Failure (AHF) Therapeutics Market to Reach $1.5 Billion by 2027 - Amid the COVID-19 crisis, the global market for Acute Heart Failure (AHF) Therapeutics estimated at US$372.9 Million in the year 2020, is projected to reach a revised size of US$1.5 Billion by 2027, growing at a CAGR of...

  • Therapy
  • Heart Failure
  • World
  • China
  • United States

Abstract: - Global Cardiovascular Drugs Market to Reach $80 Billion by 2027 - Amid the COVID-19 crisis, the global market for Cardiovascular Drugs estimated at US$79.8 Billion in the year 2020, is projected to reach a revised size of US$80 Billion by 2027, growing at a CAGR of 0% over the analysis period 2020-2027....

  • Cardiovascular Drug
  • World
  • China
  • United States

##.##.## Diuretics

  • Renal Disease
  • Middle East
  • Africa
  • Diabetes Prevalence
  • Overweight Prevalence

##.##.## Diuretics

  • Renal Disease
  • North America
  • Drug Approval
  • Final Consumption Expenditures

##.##.## Diuretics

  • Renal Disease
  • Central America
  • Brazil
  • Argentina
  • Patients Undergoing Dialysis
  • Health Expenditure

Global Kidney Stones Market 2022-2026 The analyst has been monitoring the kidney stones market and it is poised to grow by $ 416.09 mn during 2022-2026, progressing at a CAGR of 6.69% during the forecast period. Our report on the kidney stones market provides a holistic analysis, market size and forecast, trends, growth...

  • Genitourinary System Disease
  • Urology
  • World

##.##.## Diuretics

  • Renal Disease
  • APAC
  • Patients Undergoing Dialysis
  • Health Expenditure

##.##.## Diuretics

  • Renal Disease
  • Europe
  • Health Expenditure
  • Mortality Rate

Nephrology Drugs Market by Drug Class (ACE Inhibitors, Calcium Channel Blocker, Beta Blockers, Diuretics, Erythropoiesis-stimulating Agent, and Others), Route of Administration (Oral, Parenteral, and Others), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy): Global Opportunity Analysis and Industry...

  • Urology
  • Renal Disease
  • Pharmacy
  • World
  • APAC
  • Overweight Prevalence

## Diuretics

  • In-Store Retail
  • World
  • APAC
  • Europe
  • Middle East
  • Smoking Prevalence
  • Diabetes Prevalence

Antihypertensive Drugs Market – Scope of the Report This report on the global antihypertensive drugs market studies the past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market during the forecast period from 2019 to 2027.The report provides the overall...

  • Antihypertensive
  • World

Major companies in the genito-urinary drugs market include Daiichi Sankyo Company; Pfizer Inc; Bayer AG; Astellas Pharma Inc and Allergan Plc. The global genito-urinary drugs market is expected to grow from $49.24 billion in 2020 to $53.78 billion in 2021 at a compound annual growth rate (CAGR) of 9.2%. The growth is mainly due to the...

  • Pharmaceutical
  • Incontinence Product
  • Genitourinary System Disease
  • Dysfunction Drug
  • World
  • Health Expenditure
  • Population Over Age Of 65

Major players in the anti-hypertensive drugs market are Merck & Co. Inc., Astra Zeneca Plc, Daiichi Sankyo Company Limited, Johnson & Johnson Ltd., Pfizer Inc., Novartis AG, Sanofi SA, United Therapeutics, Ranbaxy Laboratories, Bayer AG, Lupin Limited, Boehringer Engelheim GmbH, and Bayer AG. The global anti-hypertensive drugs market...

  • Antihypertensive
  • World
  • APAC
  • Cause-Specific Mortality Rate

Major players in the anti-hypertensive drugs market are Merck & Co. Inc., Astra Zeneca Plc, Daiichi Sankyo Company Limited, Johnson & Johnson Ltd., Pfizer Inc., Novartis AG, Sanofi SA, United Therapeutics, Ranbaxy Laboratories, Bayer AG, Lupin Limited, Boehringer Engelheim GmbH, Sun Pharmaceuticals LLC, GlaxoSmithKline plc, Takeda Pharmaceutical...

  • Antihypertensive
  • World
  • Middle East
  • APAC
  • Cause-Specific Mortality Rate

KEY FINDINGS During the forecast period from 2019 to 2028, the global antihypertensive drugs market is estimated to grow with a CAGR of 3.21%. A surge in the prevalence of hypertension and a rise in awareness of complications related to hypertension, as well as an increase in the geriatric population and sedentary lifestyle,...

  • Hypertension
  • Antihypertensive
  • World
  • North America

Figure ##. Diuretics: Kidney Disease Market – Revenue and Forecast to 2027 (US$ Million)

  • Renal Disease
  • APAC
  • World
  • Chronic Disease Prevalence
  • Health Expenditure

Antihypertensive Drugs Market by Therapeutic Class (Diuretics, ACE Inhibitors, Calcium Channel Blockers, Vasodilators, Beta-adrenergic Blockers, and Others) and Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-commerce, and Others Distribution Channel): Global Opportunity Analysis and Industry Forecast, 2019–2026 The...

  • Antihypertensive
  • In-Store Retail
  • Pharmacy
  • Calcium Channel Blocker
  • World
  • APAC
  • Europe

Major players in the polycystic ovarian syndrome treatment market are Bristol-Myer Squibb Company, Bayer AG, Pfizer Inc., Merck KGaA, Sanofi, AstraZeneca, Novartis AG, Teva Pharmaceutical Industries Limited, Abbott, Addex Therapeutics Ltd., BIOCAD, Allergan plc., Johnson and Johnson, Ferring BV and Ferring Pharmaceuticals Inc. The global...

  • Endocrine Disease
  • World
  • Drug Approval

Major players in the polycystic ovarian syndrome treatment market are Bristol-Myer Squibb Company, Bayer AG, Pfizer Inc., Merck KGaA, Sanofi, AstraZeneca, Novartis AG, Teva Pharmaceutical Industries Limited, Abbott and Addex Therapeutics Ltd. The global polycystic ovarian syndrome treatment market is expected to grow from $3.67 billion...

  • Endocrine Disease
  • World
  • Drug Approval

The global pulmonary arterial hypertension (PAH) drugs market reached a value of US$ 6.8 Billion in 2020. Looking forward, the analyst expects the market to grow at a CAGR of 7.3% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the...

  • Hypertension
  • World
  • Medical Technology Density

Bronchopulmonary Dysplasia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Bronchopulmonary Dysplasia - Drugs In Development, 2022, provides an overview of the Bronchopulmonary Dysplasia...

  • Pharmaceutical
  • Therapy
  • Drug Development
  • World
  • Drug Approval
  • Pharmaceutical Exports

The global potassium citrate market reached a value of US$ 692.6 Million in 2021. Looking forward, the analyst expects the market to reach a value of US$ 894.2 Million by 2027, exhibiting a CAGR of 4.10% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect...

  • Healthcare
  • Research And Development
  • Personal Care
  • Urology
  • Nutraceutical
  • General Medicine And Specialty Medicine
  • Cardiovascular Disease
  • Dietary Supplement
  • Genitourinary System Disease
  • World

Amyloidosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Amyloidosis - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides...

  • Endocrine Disease
  • World
  • United Kingdom
  • Switzerland
  • Stem Cell Transplantation
  • Prescription Drug Sales

Myocarditis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Myocarditis - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides...

  • Cardiovascular Disease
  • World
  • Sweden
  • Child Mortality
  • Drug Approval

Hepatic Encephalopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Hepatic Encephalopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022...

  • Neurological Disorder
  • Drug Development
  • World
  • Ammonia Production
  • Drug Approval

Familial Amyloid Neuropathies (Metabolic Disorder) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Familial Amyloid Neuropathies – Drugs In Development, 2021, provides an overview of the Familial Amyloid Neuropathies (Metabolic Disorders) pipeline...

  • Drug Development
  • World
  • Pharmaceutical Registrations
  • Drug Approval